Navigation Links
RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
Date:9/13/2008

as been used to treat the diarrhea and flushing associated with carcinoid syndrome.

The active ingredient in Sandostatin LAR Depot, octreotide acetate, was approved in the United States in October 1988. In November 1998, the FDA approved the long-acting formulation of octreotide acetate which Novartis markets as Sandostatin LAR Depot. Through more than a decade, and 600,000 patient years of experience, Sandostatin LAR Depot has achieved a long-standing track record of sustained efficacy and a well-established safety profile.

Sandostatin LAR Depot important safety information

Adverse reactions identified in clinical studies include nausea, abdominal pain, gas, constipation, vomiting, pain on injection, high or low blood sugar levels and slow or irregular heart rate. Many patients developed gallstones, although few patients required treatment.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "potential", "to confirm", "promise", "proposed", "promising", "may", "will", or similar expressions, or by express or implied discussions regarding potential marketing approvals for RAD001 or regarding potential future revenues from RAD001. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with RAD001 to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that RAD001 will be approved for sale in any market. Nor can there be any guarantee that RAD001 will achieve any particular levels of revenue in the future. In particular, management's expectations regarding RAD001 could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpe
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
2. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
3. RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
4. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R)
9. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
10. Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add-on Therapy Studies
11. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... OAK, Mich. , March 26, 2015 ... have performed the Midwest,s first commercial implant of ... Administration for patients with non-valvular atrial fibrillation. The Watchman ... long-term use of blood-thinning warfarin medication to reduce the ... most common heart rhythm disorder affecting more than 5 ...
(Date:3/26/2015)... , March 26, 2015 When ... by their existing PACS vendor their system would ... determined that they needed a better structured solution ... selected Avreo interWORKS due to its interface capabilities ... meaningful use standards through to the hospital,s radiology ...
(Date:3/26/2015)... DALLAS , March 26, 2015  CCS ... of home medical supplies for patients with chronic ... President and Chief Executive Officer, effective March 23.  ... second-largest telehealth company, where he was President of ... Carson was President and Executive Vice President of ...
Breaking Medicine Technology:Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2
... Calif., Aug. 31 Accuray Incorporated (Nasdaq: ARAY ... today financial results for the fourth quarter and fiscal year ... fourth quarter of fiscal 2010, Accuray reported total revenue of ... of fiscal 2009 total revenue of $58.8 million. For the ...
... 31 Reportlinker.com announces that a new market research report is ... the Coronary Stent Market http://www.reportlinker.com/p0203108/All-Change-in-the-Coronary-Stent-Market.html ... the prospects for key stent sectors Evaluate how ... and split in major regions and technology sectors ...
Cached Medicine Technology:Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 2Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 3Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 4Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 5Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 6Reportlinker Adds All Change in the Coronary Stent Market 2Reportlinker Adds All Change in the Coronary Stent Market 3Reportlinker Adds All Change in the Coronary Stent Market 4Reportlinker Adds All Change in the Coronary Stent Market 5Reportlinker Adds All Change in the Coronary Stent Market 6Reportlinker Adds All Change in the Coronary Stent Market 7Reportlinker Adds All Change in the Coronary Stent Market 8Reportlinker Adds All Change in the Coronary Stent Market 9
(Date:3/26/2015)... Moreno Ranches, a top breeder of ... at the 2015 International Brahman Show and Sale, held ... many categories of show cattle for sale. , “We ... International Brahman show,” explained Kelvin Moreno, head of Moreno ... of our superior genetics is in the placements across ...
(Date:3/26/2015)... North American Seminars launches it new mobile website ... information regarding OT PT continuing education courses to the ... leader in live hands PT continuing education courses ... online continuing education courses. , Featured Live ... Clinicians Approach to Advanced Concepts in Examination and Treatment ...
(Date:3/26/2015)... New York, New York (PRWEB) March 26, 2015 ... continue to move forward nationwide, with the ... currently underway in Pennsylvania and Louisiana. According to ... the federal multidistrict litigation established for Xarelto injury ... of Louisiana will now allow plaintiffs to file ...
(Date:3/26/2015)... 26, 2015 Visiting Nurse Association ... 18th annual gala fundraiser, Lighting the Way, Brightening the ... at The Madison Hotel in Morristown, NJ. , ... by renowned musician Rio Clemente, delightful cuisine, an extensive ... Dave Hertzel. Additionally, two prestigious awards will be presented ...
(Date:3/26/2015)... 26, 2015 Pacific Medical LLC, the ... to be featured on Innovations with Ed Begley Jr, ... 2015. The episode will repeat on local cable ... the Pacific Medical home page at: http://www.pacificmedicalsupply.com . ... it is reassuring to trust the integrity of the ...
Breaking Medicine News(10 mins):Health News:Red and Gray Brahman Cattle Champions Announced by Moreno Ranches at International Brahman Show and Sale in Houston, Texas 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3
... A program which combines interval training and healthy eating ... from obesity, according to the results of a new ... medicine and physical activity (PIC Centre). Results of the ... taking place in Montreal. Within the framework of ...
... radiation oncologist practiced were two factors that strongly influenced the ... according to an article published April 29 online in ... of IMRT and the cost of radiation therapy increased sharply ... radiation delivery technique that modulates the radiation beams to conform ...
... , THURSDAY, April 28 (HealthDay News) -- Women are much ... a common heart imaging test called coronary angiography, a new ... dye is used to enhance images of the heart,s blood ... blood vessels to narrow, damaging the organ, explained Dr. Javier ...
... novel strategy developed by autism researchers at the University of ... Check Up Approach," shows promise as a simple way for ... or developmental delays in babies at an early age. ... UC San Diego Department of Neurosciences, researchers at the UC ...
... specific form of vitamin E improved the most severe form ... study funded by the National Institutes of Health. Results appear ... the American Medical Association . A previous study found vitamin ... Nonalcoholic fatty liver disease (NAFLD) is the most common chronic ...
... , WEDNESDAY, April 27 (HealthDay News) -- Gastric bypass ... often sending people with type 2 diabetes into remission, ... Now, a new study provides some clues. ... in those who have the bypass surgery, the researchers ...
Cached Medicine News:Health News:Obesity: Conclusive results for the Montreal Heart Institute's EPIC Centre Kilo-Actif program 2Health News:Use of costly breast cancer therapy strongly influenced by reimbursement policy 2Health News:Women's Kidneys May Be at Higher Risk After Heart Test 2Health News:Catching signs of autism early: The 1-year well-baby check-up approach 2Health News:Vitamin E helps diminish a type of fatty liver disease in children 2Health News:Vitamin E helps diminish a type of fatty liver disease in children 3Health News:New Clues to How Gastric Bypass Surgery Combats Diabetes 2Health News:New Clues to How Gastric Bypass Surgery Combats Diabetes 3
... FLUOstar is a flexible multifunction plate reader ... one instrument: fluorescence intensity, time-resolved fluorescence, high-perfomance ... be equipped with injectors that deliver reagent ... fast kinetic cell assays can be performed ...
The basic modular Wallac 1420 VICTOR2 is a manually operated platereader which enables luminometry, fluorometry and photometry measurements to be made....
VICTOR2 V measures prompt fluorescence, fluorescence polarization, luminescence, time-resolved fluorescence and absorbance. This model includes high density TRF (for 1536-well plates), temperature ...
This is the modular VICTOR2 multilabel counter with the TR-fluorometry, stacker and robot loading options.The addition of a xenon flash lamp brings the time-resolved fluorescence counting mode to th...
Medicine Products: